Cellular South, Inc. v. Merrill Lynch, Pierce, Fenner & Smith Inc.

886 F. Supp. 2d 340
CourtDistrict Court, S.D. New York
DecidedAugust 13, 2012
DocketNo. 10 Civ. 2653(LAP); No. 09 MD 2030 (LAP)
StatusPublished
Cited by2 cases

This text of 886 F. Supp. 2d 340 (Cellular South, Inc. v. Merrill Lynch, Pierce, Fenner & Smith Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cellular South, Inc. v. Merrill Lynch, Pierce, Fenner & Smith Inc., 886 F. Supp. 2d 340 (S.D.N.Y. 2012).

Opinion

OPINION AND ORDER

LORETTA A. PRESKA, Chief Judge:

Plaintiff, Cellular South, Inc. (“Cellular South” or “Plaintiff’), brings this action alleging federal and state causes of action against Defendant Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill”). The action alleges that Defendant’s activities related to certain auction rate securities (“ARS”) purchased by Plaintiff ran afoul of the law. Merrill served as the underwriter, placement agent, and auction dealer of the relevant ARS at issue in this case. Merrill moves to dismiss the First Amended Complaint (“Compl.”) under Fed.R.Civ.P. 9(b) and 12(b)(6) as well as Section 21D(b) of the Private Securities Litigation Reform Act of 1995, 15 U.S.C. § 78u-4(b) (the “PSLRA”).

Taking as true the factual allegations in the complaint and drawing all reasonable inferences in favor of Plaintiff, Goldstein v. [343]*343Pataki 516 F.3d 50, 56 (2d Cir.2008), the Court concludes that the complaint fails to state a claim. For the reasons stated below, Merrill’s motion to dismiss is therefore granted in its entirety and with prejudice.

I. BACKGROUND

Plaintiff alleges that between August 13, 2007 and January 25, 2008, it purchased from Merrill some $26 million worth of various ARS. (See Compl. ¶¶ 1, 42.) These purchases included an August 2007 purchase of some $20 million in ARS connected to preferred stock issued by the Federal Home Loan Mortgage Corporation (“Freddie Mac”), an October 2007 purchase of approximately $2.6 million in ARS issued by the Federal National Mortgage Association (“Fannie Mae”), and January 2008 purchases of some $2.4 million in additional Fannie Mae ARS and approximately $1 million in Bank of America ARS. (See Compl. Ex. 1.) Although these ARS contained their own particularities, (see, e.g., Declaration of Carl S. Burkhalter in Support of Defendant’s Motion to Dismiss Plaintiffs First Amended Complaint (“Burkhlater Deck”) Ex. C (attaching excerpts of the Freddie Mac ARS Private Placement Memorandum (“Freddie Mac Offering Memorandum”)), the details and operation of the ARS here are not materially different from the ARS described in other opinions in this Multidistrict Litigation. The Court thus presumes familiarity with the ARS structure, the May 2006 Securities & Exchange Commission Order as to Merrill (the “SEC Order”), and Merrill’s subsequent widely available public website disclosure regarding its ARS practices (the “Website Disclosure”), as previously discussed. See generally In re Merrill Lynch ARS Litig. (Merrill IV), 851 F.Supp.2d 512 (S.D.N.Y.2012); In re Merrill Lynch ARS Litig. (Merrill III), No. 09 MD 2030; 09 Civ. 9888, 2011 WL 536437 (S.D.N.Y. Feb. 9, 2011); In re Merrill Lynch ARS Litig. (Merrill II), 758 F.Supp.2d 264 (S.D.N.Y.2010); In re Merrill Lynch ARS Litig. (Merrill I), 704 F.Supp.2d 378 (S.D.N.Y.2010), aff'd, 671 F.3d 120 (2d Cir.2011).

II. DISCUSSION

Cellular South asserts claims against Merrill for market manipulation and material misstatements and omissions under section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder. See 15 U.S.C. § 78j(b); 17 C.F.R. § 240.10b-5. Plaintiff also asserts independent violations of the North Carolina Securities Act, N.C. GemStat. §§ 78A-8, 78A-56(a)(2), and Mississippi Securities Act, Miss. Code Ann. § 75-71-717(a)(2). Finally, Plaintiff asserts common law claims for breach of contract and breach of the implied covenant of good faith and fair dealing, for negligent and/or fraudulent misrepresentations and omissions, and for promissory estoppel. Merrill moves to dismiss all of these claims. The Court addresses them in turn.

A. Legal Standard

In assessing a motion to dismiss, the Court must accept all non-conclusory factual allegations as true and draw all reasonable inferences in the Plaintiffs favor. Goldstein v. Pataki 516 F.3d 50, 56 (2d Cir.2008). To survive such a motion, “a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). A pleading that offers “labels and conclusions” or “a formalistic recitation of the elements of a cause of action will not do.” Twombly, 550 U.S. at 555, 127 S.Ct. [344]*3441955. “Where a complaint pleads facts that are ‘merely consistent with’ a defendant’s liability, it ‘stops short of the line between possibility and plausibility of entitlement to relief.’ ” Iqbal, 556 U.S. at 678, 129 S.Ct. 1937 (quoting Twombly, 550 U.S. at 557, 127 S.Ct. 1955). For federal securities law violation claims, the complaint must also meet the heightened pleading requirements under Fed.R.Civ.P. 9(b) and, for federal claims, the PSLRA, 15 U.S.C. § 78u-4(b). ATSI Commc’ns, Inc. v. Shaar Fund, Ltd. (ATSI I), 493 F.3d 87, 99 (2d Cir.2007).

B. Cellular South’s Section 10(b) and Rule 10b5 Claims

1. Plaintiff Fails to State a Claim

The Court incorporates in its entirety its misstatement/omission analysis of these same federal claims as recently articulated in Merrill IV, 851 F.Supp.2d at 524-31, 532-40. As there, Plaintiff is a large institutional investor and all of Plaintiffs purchases underpinning the claims occurred after January 2007 (here, not until August 13, 2007). (See Compl. ¶¶ 1, 42.) These purchases occurred well after Merrill produced its Website Disclosure and even further after the May 2006 SEC Order. See also Merrill III, 2011 WL 536437, at *5-10; Merrill II, 758 F.Supp.2d at 277-301; Merrill I, 704 F.Supp.2d at 387-402. This Court has held squarely in this Multidistrict Litigation that these same disclosures “relieve [Merrill] of liability on Plaintiffs misstatement and market manipulation claims based on purchases made after the Website Disclosure.” Merrill III, 2011 WL 536437, at *6. The claims in Merrill IV that Merrill (and, to a lesser extent, Money Market One Institutional Investment Dealer) made material misstatements or omissions are, in substance, analogous in all material legal respects to the same claims advanced here.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
886 F. Supp. 2d 340, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cellular-south-inc-v-merrill-lynch-pierce-fenner-smith-inc-nysd-2012.